Results 21 to 30 of about 222,830 (234)

High-Throughput Precision Phenotyping of Left Ventricular Hypertrophy with Cardiovascular Deep Learning [PDF]

, 2021
Left ventricular hypertrophy (LVH) results from chronic remodeling caused by a broad range of systemic and cardiovascular disease including hypertension, aortic stenosis, hypertrophic cardiomyopathy, and cardiac amyloidosis. Early detection and characterization of LVH can significantly impact patient care but is limited by under-recognition of ...
arxiv   +1 more source

Hypertrophic Cardiomyopathy

Medical Journal of Dr. D.Y. Patil Vidyapeeth, 2022
Hypertrophic cardiomyopathy (HCM) is a primary disease affecting the cardiac muscle and is characterized by heterogeneous genetic, morphological, functional and clinical features. The clinical presentation of HCM varies widely. Patients may be completely asymptomatic and identified incidentally.
Sarita Gore, Sunil Yogiraj Swami
openaire   +2 more sources

2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Circulation, 2020
Aim This executive summary of the hypertrophic cardiomyopathy clinical practice guideline provides recommendations and algorithms for clinicians to diagnose and manage hypertrophic cardiomyopathy in adult and pediatric patients as well as supporting ...
S. Ommen, S. Mital, Michael A. Burke, S. Day, A. Deswal, P. Elliott, Lauren L. Evanovich, J. Hung, J. Joglar, P. Kantor, C. Kimmelstiel, M. Kittleson, M. Link, M. Maron, Matthew W. Martinez, C. Miyake, H. Schaff, C. Semsarian, Sorajja Paul   +18 more
semanticscholar   +1 more source

The Feline Cardiomyopathies: 2. Hypertrophic cardiomyopathy

Journal of feline medicine and surgery, 2021
Practical relevance: Hypertrophic cardiomyopathy (HCM) is the most common form of feline cardiomyopathy observed clinically and may affect up to approximately 15% of the domestic cat population, primarily as a subclinical disease. Fortunately, severe HCM,
M. Kittleson, E. Côté
semanticscholar   +1 more source

Availability and Utilization of Automated External Defibrillators in New York State Schools

Frontiers in Pediatrics, 2021
Background: Use of automated external defibrillators (AEDs) in out-of-hospital cardiac arrests (OHCAs) improve survival. Professional health organizations recommend that AEDs be available in crowded places, including schools but currently only 18 US ...
Milla Arabadjian, Milla Arabadjian, Stephanie Serrato, Mark V. Sherrid   +3 more
doaj   +1 more source

Differences in molecular phenotype in mouse and human hypertrophic cardiomyopathy

Scientific Reports, 2021
Hypertrophic cardiomyopathy (HCM) is characterized by phenotypic heterogeneity. We investigated the molecular basis of the cardiac phenotype in two mouse models at established disease stage (mouse-HCM), and human myectomy tissue (human-HCM).
Styliani Vakrou, Yamin Liu, Li Zhu, Gabriela V. Greenland, Bahadir Simsek, Virginia B. Hebl, Yufan Guan, Kirubel Woldemichael, Conover C. Talbot, Miguel A. Aon, Ryuya Fukunaga, M. Roselle Abraham   +11 more
doaj   +1 more source

COVID-19 in Adults With Hypertrophic Cardiomyopathy

Frontiers in Cardiovascular Medicine, 2021
Background: Individuals with cardiovascular disease are considered high risk for severe COVID-19. However, the clinical impact of COVID-19 in patients with hypertrophic cardiomyopathy (HCM) is unknown.
Milla E. Arabadjian, Maria C. Reuter, Alexandra Stepanovic, Mark V. Sherrid, Daniele Massera   +4 more
doaj   +1 more source

Hypertrophic Cardiomyopathy With Left Ventricular Systolic Dysfunction

Circulation, 2020
Supplemental Digital Content is available in the text. Background: The term “end stage” has been used to describe hypertrophic cardiomyopathy (HCM) with left ventricular systolic dysfunction (LVSD), defined as occurring when left ventricular ejection ...
Peter Marstrand, Larry Han, S. Day, I. Olivotto, E. Ashley, M. Michels, A. Pereira, S. Wittekind, A. Helms, S. Saberi, D. Jacoby, J. Ware, S. Colan, C. Semsarian, J. Ingles, N. Lakdawala, Carolyn Y. Ho   +16 more
semanticscholar   +1 more source

Acute Left Ventricular Ballooning: Tools to Differentiate Hypertrophic Cardiomyopathy with Outflow Obstruction from Neurohumoral Takotsubo Syndrome

Reviews in Cardiovascular Medicine, 2023
Despite considerable interest in the syndrome of acute left ventricular (LV) ballooning, its pathophysiology has remained ill-defined. In this review, we explore observational data describing two etiologies of acute LV ballooning: neurohumoral classic ...
Arushi Singh, Louai Razzouk, Daniele Massera, Mark V. Sherrid   +3 more
doaj   +1 more source

A Validated Model for Sudden Cardiac Death Risk Prediction in Pediatric Hypertrophic Cardiomyopathy

Circulation, 2020
Supplemental Digital Content is available in the text. Background: Hypertrophic cardiomyopathy is the leading cause of sudden cardiac death (SCD) in children and young adults.
A. Miron, M. Lafreniere-Roula, Chun-Po Steve Fan, K. Armstrong, A. Dragulescu, Tanya Papaz, C. Manlhiot, B. Kaufman, R. Butts, L. Gardin, E. Stephenson, Taylor S. Howard, P. Aziz, S. Balaji, Virginie Beauséjour Ladouceur, L. Benson, S. Colan, J. Godown, H. Henderson, J. Ingles, A. Jeewa, J. Jefferies, A. Lal, J. Mathew, E. Jean-St-Michel, M. Michels, S. Nakano, I. Olivotto, J. Parent, A. Pereira, C. Semsarian, R. Whitehill, S. Wittekind, M. Russell, J. Conway, M. Richmond, C. Villa, R. Weintraub, J. Rossano, P. Kantor, Carolyn Y. Ho, S. Mital   +41 more
semanticscholar   +1 more source